Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

HIF2a RNAi ARO-HIF2

An RNA interference (RNAi) targeting hypoxia-inducible factor 2alpha (HIF-2a), with potential antineoplastic activity. Upon administration of HIF2a RNAi ARO-HIF2, the agent binds to and neutralizes mRNA HIF2a, thereby preventing the production of HIF2a. This may lead to an inhibition of tumor cell proliferation. HIF2a, overexpressed in certain cell types, plays a key role in proliferation, progression and metastasis of tumors.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	RNA interference therapeutic ARO-HIF2 targeted RNAi molecule ARO-HIF2 TRiM ARO-HIF2
Code name:	ARO HIF2 ARO-HIF2 AROHIF2

HIF2a RNAi ARO-HIF2

Search NCI's Drug Dictionary